- Toxicity of Tomotherapy-Based Simultaneous Integrated Boost in Whole-Pelvis Radiation for Prostate Cancer
-
You SH, Lee JY, Lee CG
- KMID: 2070032
- Yonsei Med J.
- 2015 Mar;56(2):510-518.
- doi: 10.3349/ymj.2015.56.2.510
PURPOSE: The validity of tomotherapy-based simultaneous integrated boost (TOMOSIB) was assessed in terms of acute intestinal/urinary toxicity by comparing with 3-dimensional conformal radiotherapy (3DCRT) in cases of whole-pelvis radiation therapy... -
- CITED
-
- Close
- SHARE
-
- Close
- Outcomes of Gleason Score < or =8 among High Risk Prostate Cancer Treated with 125I Low Dose Rate Brachytherapy Based Multimodal Therapy
-
Park DS, Gong IH, Choi DK, Hwang JH, Shin HS, Oh JJ
- KMID: 1793169
- Yonsei Med J.
- 2013 Sep;54(5):1207-1213.
- doi: 10.3349/ymj.2013.54.5.1207
PURPOSE: To investigate the role of low dose rate (LDR) brachytherapy-based multimodal therapy in high-risk prostate cancer (PCa) and analyze its optimal indications. MATERIALS AND METHODS: We reviewed the records of... -
- CITED
-
- Close
- SHARE
-
- Close
